Dr. Agarwal's Health Care IPO: Price Dates and Apply Steps

Don't worry if you don't have a Demat account—open one now and get ready to apply for this exciting IPO! 
Company Overview

Dr. Agarwal's Health Care Limited, incorporated in 2010 and headquartered in Chennai, is a leading provider of advanced eye care services. The company operates a robust network of specialized eye hospitals across India and abroad, offering treatments such as cataract surgeries, LASIK procedures, glaucoma management, and retinal treatments. Known for its commitment to innovation, the company leverages cutting-edge technology, including robotic and laser-assisted procedures, to deliver superior patient outcomes.

The company is promoted by the Agarwal family, including renowned ophthalmologists Dr. Amar Agarwal, Dr. Athiya Agarwal, and Dr. Adil Agarwal, along with family trusts. Over the years, it has expanded its presence into Tier 2 and Tier 3 cities in India and international markets, cementing its reputation as a trusted name in the eye care industry. Its focus on high-quality care, operational efficiency, and customer satisfaction has enabled it to maintain steady financial growth.

With its upcoming IPO, Dr. Agarwal's aims to raise funds for expanding its hospital infrastructure, meeting working capital needs, and supporting corporate growth initiatives. Positioned in a rapidly growing eye care market, the company is poised to capitalize on increasing demand for specialized and high-quality healthcare services in India and globally.

Key Performance Indicator

The market capitalization of Dr. Agarwal's Health Care Limited IPO is Rs 12698.37 Cr.

KPI as of March 31, 2024.

Financial Summary

Download RHP

Industry Outlook

The eye care sector is a rapidly growing segment within the global healthcare industry, driven by increasing awareness of vision health, advancements in technology, and rising cases of eye disorders. The global eye care market is projected to grow at a CAGR of 5–7%, while the Indian market is expected to expand at 6–8% CAGR in the coming years, fuelled by an aging population, urbanization, and greater access to healthcare services.

In India, the demand for eye care is increasing due to the rising prevalence of conditions such as cataracts, glaucoma, and diabetic retinopathy. Additionally, the widespread use of digital screens has led to a surge in myopia and digital eye strain cases, particularly among younger demographics. Government initiatives, coupled with private sector investments, are also improving access to specialized eye care services in Tier 2 and Tier 3 cities, bridging the urban-rural healthcare divide.

The industry's growth is further propelled by technological advancements such as AI-based diagnostics, telemedicine, and robotic-assisted surgeries, which enhance the precision and accessibility of treatments. With increasing insurance penetration and disposable incomes, the affordability of eye care services has improved, attracting significant investments and consolidations within the sector. These trends position the eye care industry as a promising opportunity for stakeholders and investors.

Peer companies

The companies considered by Dr. Agarwal's Health Care Limited as its peers include:

1. Apollo Hospitals Enterprise Limited

2. Fortis Healthcare Limited

3. Max Healthcare Institute Limited

4. Narayana Hrudayalaya Limited

5. Shalby Limited

Strengths

1. Strong Brand Presence: A well-established and trusted name in the eye care industry, known for its specialized services and patient-centric approach.

2. Wide Network of Hospitals: Extensive presence across India, including Tier 2 and Tier 3 cities, along with a growing international footprint.

3. Advanced Technology: Use of cutting-edge technology, including robotic and laser-assisted surgeries, AI-based diagnostics, and telemedicine for superior treatment outcomes.

4. Experienced Promoters and Leadership: Led by renowned ophthalmologists with decades of experience, providing strategic direction and clinical expertise.

5. Diverse Service Portfolio: Comprehensive range of eye care services, including cataract, LASIK, glaucoma, and retinal treatments, catering to various patient needs.

6. Operational Efficiency: Focus on high-margin procedures, cost management, and consistent financial growth.

Risks

1. Economic and Market Conditions: Adverse economic conditions or reduced discretionary spending by patients could impact the uptake of elective surgeries and premium services.

2. Technological Dependency: The company relies heavily on advanced technology for treatments. Any failure to adapt to newer technologies or manage associated costs could pose a risk.

3. IPO Risks: Being its first public offering, there is no assurance of sustained trading or stability in stock prices post-listing, which could affect investor confidence.

4. High Competition: The eye care market faces intense competition from established players, multi-specialty hospitals, and emerging standalone clinics, which could impact market share

How to Apply for Dr. Agarwal's Health Care Limited IPO Online?

1. Go to https://ipo.adityatrading.in/

2. Enter your Client ID

3. Enter the OTP received in your registered mobile number.

4. Choose the IPO and click on apply button.

5. Enter the UPI ID, Quantity, and Cut off the price.

6. Click on submit button

7. Confirm the mandate request received on your phone by entering the UPI Pin.

You can also watch our youtube video on “How to Apply on IPO” by clicking on the link
https://youtu.be/1qOI8dCpl1I?si=KmuKYTRjQULG5kJi

Check out our blog posts for expert insights, stock analysis, market trends, and the latest updates in the online stock market!